On another front, this study is the first to report the clinical relevance of anti-SMN antibody titers in SLE, demonstrating correlations with key clinical metrics, including cytopenia, anti-ds-DNA antibody titer, complement reduction, various organ involvement, and SLEDAI. The gene discussed is SMN1; the disease is systemic lupus erythematosus.